Evaluation of YKL-40 as a Biomarker of Inflammation and Atherosclerosis in Chronic Kidney Disease Patients
Omar Ali Abdel Naby El-Ghorab, Mohamed Hassan Rashad Elshafey, Manal Saad Ahmed Negm & Mervat Abdel-Hameed Taha Elkhateeb · Journal of Advances in Medicine and Medical Research · 2022
Background: Chronic kidney disease (CKD) has been recognized as a leading public health problem worldwide. In Egypt, CKD approximately affects 13% of the adult population, resulting in significant morbidity, mortality, and health care costs. Patients with advanced CKD (stage 3 or...
Open access
Research Article
10.9734/jammr/2022/v34i2131520